Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Neptune Wellness Solutions (NEPT) will report the company’s financial results from the third quarter of fiscal 2020, before markets open on February 13th.
  • After the financial results are released, Neptune will host a conference call to discuss the financial results from October, November, and December of 2019.
  • The conference call will take place at 8:30am (EST) on February 13th 2020.
  • A replay of the call will be available online for a month.
  • Neptune’s share price is down 1.17 per cent, with shares trading at $3.37 apiece.

Before markets open on February 13th, biotechnology company Neptune Wellness (NEPT) will report the company’s financial results from fiscal 2020’s third quarter.

After the results are released, Neptune will hold a conference call, to discuss results for the 3 month period which ended on December 31st 2019.

The conference call (ID 8708188) will take place on Thursday, February 13th 2020, at 8:30am Eastern Standard Time.

For investors from Canada and the United States, the call number will be 1 (888) 231-8191. For all international investors, the call number will be 1 (647) 427-7450.

A replay of the call will be available online on Neptune’s website, under Investor Events and Presentations. The replay will be accessible until March 13th 2020.

Neptune’s share price is down 1.17 per cent, with shares trading at $3.37 apiece.

More From The Market Herald

" Algernon Pharmaceuticals (CSE:AGN) discloses novel salt patent strategy

Algernon Pharmaceuticals (AGN) has included novel salt forms of DMT in its intellectual property patent applications for AP-188 (“N,N-dimethyltryptamine” or “DMT”).

" LevelJump Healthcare (TSXV:JUMP) announces $2.5M private placement

LevelJump Healthcare (JUMP) will be conducting a non-brokered private placement financing for gross proceeds of up to $2,500,000.

" Leveljump Healthcare (TSXV:JUMP) provides corporate update

Leveljump Healthcare (JUMP) has agreed to acquire an additional minority interest in Real Time Medical (RTM), Shaw Lens, and Shaw Vision.

" PharmaDrug (CSE:PHRX) engages Octagon Media for an investor marketing campaign

PharmaDrug Inc. (PHRX) has engaged Octagon Media Corp to assist in a digital media advertising campaign coupled with an investor marketing program.